Dirt Devil vs Kenvue
Side-by-side comparison of AI visibility scores, market position, and capabilities
TTI-owned budget vacuum brand with $50M+ revenue; Versa 3-in-1 launch in 2024 targeting value floor care segment; Walmart exclusive models leverage TTI's global manufacturing scale alongside Milwaukee Tool, Ryobi, and Hoover sister brands.
About
Dirt Devil is an American cleaning appliance brand with origins in 1905, when the Royal Appliance Manufacturing Company introduced its first electric floor care products. The Dirt Devil name was established in 1984 with the launch of a compact handheld vacuum that became one of the best-selling cleaning appliances in US retail history, popularizing the lightweight supplemental vacuum category. The brand is now owned by Techtronic Industries (TTI), the Hong Kong-based conglomerate that also owns Milwaukee Tool, Ryobi, and Hoover — providing global manufacturing scale and retail distribution infrastructure.\n\nDirt Devil's lineup concentrates on the value floor care segment: upright vacuums, stick vacuums, handheld vacuums, and multi-surface cleaners priced for budget-conscious consumers. The Versa 3-in-1 convertible vacuum, launched in 2024, exemplifies the brand's versatile, affordable positioning for apartment dwellers and secondary vacuum users. Products are sold primarily through Walmart, Target, and Amazon, with Walmart-exclusive models representing a significant share of US volume. The brand generates $50 million or more in annual revenue competing against Bissell, Eureka, and Black+Decker.\n\nDirt Devil's competitive advantage combines strong brand heritage recognition — the Dirt Devil name carries high awareness from 1980s and 1990s household penetration — with TTI's manufacturing cost efficiency. While Dyson and Shark have captured premium share, the sub-$100 segment where Dirt Devil competes remains large, driven by first-time household formation and secondary vacuum purchases. Walmart exclusivity strategy ensures volume while TTI's scale manages margin.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
About
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.